Organogels based on amino acid derivatives and their optimization for drug release using response surface methodology

References

• Wang C, Li Z, Wang X, et al. Gelation mechanism and microstructure of organogels formed with L-Valine dihydrazide derivatives. Colloid Surf A. 2011;384(1–3):490–495.
   Web of Science ®Google Scholar
• Su MM, Yang HK, Ren LJ, et al. Solvent-mediated gel formation, hierarchical structures, and rheological properties of organogels. Soft Matter. 2015;11(4):741–748.
   PubMed Web of Science ®Google Scholar
• Martin-Illana A, Cazorla-Luna R, Notario-Perez F, et al. Freeze-dried bioadhesive vaginal bigels for controlled release of Tenofovir. Eur J Pharm Sci. 2019;127:38–51.
   PubMed Web of Science ®Google Scholar
• Singh VK, Pramanik K, Ray SS, et al. Development and characterization of sorbitan monostearate and sesame oil-based organogels for topical delivery of antimicrobials. AAPS PharmSciTech. 2015;16:293–305.
   PubMed Web of Science ®Google Scholar
• Behera B, Sagiri SS, Pal K, et al. Modulating the physical properties of sunflower oil and sorbitan monopalmitate‐based organogels. J Appl Polym Sci. 2013;127(6):4910–4917.
   Web of Science ®Google Scholar
• Sravan B, Kamalakar K, Karuna MSL, et al. Studies on organogelation of self assembling bis urea type low molecular weight molecules. J Sol-Gel Sci Technol. 2014;71(2):372–379.
   Web of Science ®Google Scholar
• Cao X, Zhao X, Gao A, et al. Organogel formation based on bis-urea derivative. Supramol Chem. 2014;26(10–12):804–808.
   Web of Science ®Google Scholar
• Wang D, Zhao J, Liu X, et al. Parenteral thermo-sensitive organogel for schizophrenia therapy, in vitro and in vivo evaluation. Eur J Pharm Sci. 2014;60:40–48.
   PubMed Web of Science ®Google Scholar
• Sagiri S, Behera B, Rafanan R, et al. Organogels as matrices for controlled drug delivery: a review on the current state. Soft Mater. 2014;12(1):47–72.
   Web of Science ®Google Scholar
• Jiao T, Wang Y, Zhang Q, et al. Regulation of substituent groups on morphologies and self-assembly of organogels based on some azobenzene imide derivatives. Nanoscale Res Lett. 2013;8(1):1–8.
   PubMedGoogle Scholar
• Pal A, Dey J. Gelation of organic solvents by N-(n-tetradecylcarbamoyl)-l-amino acids. Supramol Chem. 2015;27(1–2):127–135.
   Web of Science ®Google Scholar
• Vigato AA, Querobino SM, de Faria NC, et al. Synthesis and characterization of nanostructured lipid-poloxamer organogels for enhanced skin local anesthesia. Eur J Pharm Sci. 2019;128:270–278.
   PubMed Web of Science ®Google Scholar
• Wang K, Jia Q, Han F, et al. Self-assembled L-alanine derivative organogel as in situ drug delivery implant: characterization, biodegradability, and biocompatibility. Drug Dev Ind Pharm. 2010;36(12):1511–1521.
   PubMed Web of Science ®Google Scholar
• Samai S, Dey J, Biradha K. Amino acid based low-molecular-weight tris (bis-amido) organogelators. Soft Matter. 2011;7(5):2121–2126.
   Web of Science ®Google Scholar
• Bastiat G, Plourde F, Motulsky A, et al. Tyrosine-based rivastigmine-loaded organogels in the treatment of Alzheimer's disease. Biomaterials. 2010;31(23):6031–6038.
   PubMed Web of Science ®Google Scholar
• Vintiloiu A, Lafleur M, Bastiat G, et al. In situ-forming oleogel implant for rivastigmine delivery. Pharm Res. 2008;25(4):845–852.
   PubMed Web of Science ®Google Scholar
• Dou QQ, Liow SS, Ye E, et al. Biodegradable thermogelling polymers: working towards clinical applications. Adv Healthcare Mater. 2014;3(7):977–988.
   Web of Science ®Google Scholar
• Jangdey MS, Kaur CD, Saraf S. Efficacy of Concanavalin-A conjugated nanotransfersomal gel of apigenin for enhanced targeted delivery of UV induced skin malignant melanoma. Artif Cells Nanomed Biotechnol. 2019;47(1):904–916.
   PubMed Web of Science ®Google Scholar
• Hatefi A, Amsden B. Biodegradable injectable in situ forming drug delivery systems. J Control Release. 2002;80(1-3):9–28.
   PubMed Web of Science ®Google Scholar
• Zhang T, Luo J, Peng Q, et al. Injectable and biodegradable phospholipid-based phase separation gel for sustained delivery of insulin. Colloids Surf B Biointerfaces. 2019;176:194–201.
   PubMed Web of Science ®Google Scholar
• Chaulagain B, Jain A, Tiwari A, et al. Passive delivery of protein drugs through transdermal route. Artif Cells Nanomed Biotechnol. 2018;46(sup1):472–487.
   PubMed Web of Science ®Google Scholar
• Yang Y, Xu L, Gao Y, et al. Improved initial burst of estradiol organogel as long-term in situ drug delivery implant: formulation, in vitro and in vivo characterization. Drug Dev Ind Pharm. 2012;38(5):550–556.
   PubMed Web of Science ®Google Scholar
• Ohsedo Y, Taniguchi M, Oono M, et al. Creation of thixotropic multicomponent alkylamide organogels containing non-volatile oil as potential drug release host materials. RSC Adv. 2014;4(67):35484–35488.
   Web of Science ®Google Scholar
• Bae KH, Lee F, Xu K, et al. Microstructured dextran hydrogels for burst-free sustained release of PEGylated protein drugs. Biomaterials. 2015;63:146–157.
   PubMed Web of Science ®Google Scholar
• Thedrattanawong C, Manaspon C, Nasongkla N. Controlling the burst release of doxorubicin from polymeric depots via adjusting hydrophobic/hydrophilic properties. J Drug Deliv Sci Tec. 2018;46:446–451.
   Web of Science ®Google Scholar
• Geng Z, Luo X, Zhang Z, et al. Study of an injectable in situ forming gel for sustained-release of Ivermectin in vitro and in vivo. Int J Biol Macromol. 2016;85:271–276.
   PubMed Web of Science ®Google Scholar
• Din FU, Kim DW, Choi JY, et al. Irinotecan-loaded double-reversible thermogel with improved antitumor efficacy without initial burst effect and toxicity for intramuscular administration. Acta Biomater. 2017;54:239–248.
   PubMed Web of Science ®Google Scholar
• Li Y, Angelova A, Liu J, et al. In situ phase transition of microemulsions for parenteral injection yielding lyotropic liquid crystalline carriers of the antitumor drug bufalin. Colloids Surf B Biointerfaces. 2019;173:217–225.
   PubMed Web of Science ®Google Scholar
• Hu B, Wang W, Wang Y, et al. Degradation of glutamate-based organogels for biodegradable implants: in vitro study and in vivo observation. Mater Sci Eng C Mater Biol Appl. 2018;82:80–90.
   PubMed Web of Science ®Google Scholar
• Li Z, Cao J, Hu B, et al. Studies on the in vitro and in vivo degradation behavior of amino acid derivative-based organogels. Drug Dev Ind Pharm. 2016;42(11):1732–1741.
   PubMed Web of Science ®Google Scholar
• Li Z, Cao J, Li H, et al. Self-assembled drug delivery system based on low-molecular-weight bis-amide organogelator: synthesis, properties and in vivo evaluation. Drug Deliv. 2016;23(8):3168–3178.
   PubMed Web of Science ®Google Scholar
• Hu B, Sun W, Li H, et al. Systematic modifications of amino acid-based organogelators for the investigation of structure-property correlations in drug delivery system. Int J Pharm. 2018;547(1–2):637–647.
   PubMedGoogle Scholar
• Qiao Z, Yuan Z, Zhang W, et al. Preparation, in vitro release and antibacterial activity evaluation of rifampicin and moxifloxacin-loaded poly(D,L-lactide-co-glycolide) microspheres. Artif Cells Nanomed Biotechnol. 2019;47(1):790–798.
   PubMed Web of Science ®Google Scholar
• USP. Semisolid drug products–performance tests. USP 37/NF 32. Rockville, USA: The United States Pharmacopeial Convention; 2014. p. 1273–1284.
   Google Scholar
• Fachel FNS, Medeiros-Neves B, Dal Pra M, et al. Box-Behnken design optimization of mucoadhesive chitosan-coated nanoemulsions for rosmarinic acid nasal delivery-in vitro studies. Carbohydr Polym. 2018;199:572–582.
   PubMed Web of Science ®Google Scholar
• Sabbagh F, Muhamad II, Nazari Z, et al. From formulation of acrylamide-based hydrogels to their optimization for drug release using response surface methodology. Mater Sci Eng C Mater Biol Appl. 2018;92:20–25.
   PubMed Web of Science ®Google Scholar